Khine K, Smith D R, Goh H S
Department of Colorectal Surgery, Singapore General Hospital, Singapore.
Ann Acad Med Singap. 1996 Jan;25(1):64-70.
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are the most well-defined heritable conditions which predispose to colorectal cancer at a young age. Significant progress in understanding the pathogenesis of FAP and HNPCC has led to the development of techniques which can be used for the diagnosis of these two conditions. In this article, the technical aspects and clinical applications of molecular methods such as linkage analysis, mutational analysis and in vitro synthesised-protein assay for FAP and microsatellite instability or replication error (RER) assay for HNPCC are described and discussed. The potential of such molecular tests is the identification of affected individuals for proper surveillance and management as well as the identification of non-affected individuals to free them from the trauma of uncertainty and repeated unnecessary colonoscopies.
家族性腺瘤性息肉病(FAP)和遗传性非息肉病性结直肠癌(HNPCC)是最明确的遗传性疾病,易导致年轻人患结直肠癌。在理解FAP和HNPCC发病机制方面取得的重大进展促使了可用于诊断这两种疾病的技术的发展。本文描述并讨论了用于FAP的连锁分析、突变分析和体外合成蛋白测定以及用于HNPCC的微卫星不稳定性或复制错误(RER)测定等分子方法的技术方面和临床应用。此类分子检测的潜力在于识别受影响个体以进行适当的监测和管理,以及识别未受影响个体,使他们免受不确定性的创伤和反复不必要的结肠镜检查。